Case scenario

A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.

At a multidisciplinary professional development event, a local GP, Dr Slotz, tells you that prescribing for patients with insomnia places her in a dilemma, as she understands the risks associated with benzodiazepine and non-benzodiazepine hypnotic use. She was wondering about any new medicines on the horizon to help aid sleep.

Learning objectives

After reading this article, pharmacists should be able to:

  • Discuss the physiology of sleep
  • Describe current treatment options for insomnia
  • Discuss novel and emerging treatments for insomnia.

Compete

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.

CPD LOGIN
Click here to become a member

RELATED ARTICLESMORE FROM AUTHOR